Updated:
Maryland Innovation Initiative
The Maryland Innovation Initiative (MII) was created in 2012 under then-Chancellor William E.
Maryland Innovation Initiative
The Maryland Innovation Initiative (MII) was created in 2012 under then-Chancellor William E. Kirwan as a partnership between the state of Maryland and five public research universities: University of Maryland (College Park, Baltimore, and Baltimore County), Morgan State University, and Johns Hopkins University. The program emerged from a legislative push to commercialize federally funded research, making Maryland one of the first states to dedicate a structured fund exclusively to translating academic IP into startup equity. MII operates as a pre-seed and seed-stage fund, providing grants of $100K to $300K directly to university-affiliated startups that have disclosed an invention. The fund covers technology validation, prototype development, and initial market assessment, but explicitly requires a co-investment commitment from an external venture partner — a structure that forces market validation before public capital enters. Portfolio investments span cybersecurity, life sciences, AI/ML, and advanced manufacturing. Notable graduates include surgical robotics maker Galen Robotics (Johns Hopkins spinout), personalized cancer therapy firm OncoC4, and AI-powered radiology platform Covera Health. Since inception, MII has deployed approximately $150M into more than 100 portfolio companies, which have collectively raised over $1.5B in follow-on venture funding. The program is administered out of the University of Maryland, College Park campus, with satellite offices in Baltimore and Columbia. MII also coordinates with Maryland's broader economic development infrastructure, including the Maryland Technology Development Corporation (TEDCO), which manages similar state-backed venture programs targeting later stages. What distinguishes MII structurally is its mandated co-investment model — no grant is awarded without a matched external venture commitment. This acts as a gate, ensuring that taxpayer capital only flows into IP that professional technology investors have already vetted. Additionally, MII's governance is anchored at the University System of Maryland level, not within a single institution, which gives it the mandate to draw deal flow from multiple competing research campuses — a structure closer to a multi-LP fund-of-research-labs than a traditional university proof-of-concept center.
General information
Firm type
other
Year founded
2012
AUM
$150M - $250M (Altss estimate)
Location
Region
North America
Country
United States
City
College Park
Corporate office
College Park, MD, United States
Additional offices
Baltimore, MD · Columbia, MD
Principals
William E. Kirwan
Chairman (founding)
Sector focus
Frequently asked questions
Who runs investment decisions at Maryland Innovation Initiative?
Investment decisions are made by an executive committee composed of representatives from each of the five partner universities, alongside independent technology transfer experts. Day-to-day operations are managed by a director based at the University of Maryland, College Park. Final grant approvals require both scientific merit review and confirmation of the required external co-investor commitment.
How does MII source deal flow?
Deal flow originates exclusively from invention disclosures filed at the technology transfer offices of the five partner universities: UMD College Park, UMD Baltimore, UMBC, Morgan State, and Johns Hopkins. Researchers must have disclosed the IP to their university's commercialization office before applying. This closed-loop sourcing model means MII does not accept unsolicited applications from founders without a university affiliation.
What is the co-investment requirement?
MII requires a matched commitment from an external venture investor — typically an angel group, seed fund, or corporate venture arm — before a grant is awarded. The external investor must commit capital at the time of MII's award, and the terms are negotiated independently between the startup and the investor. This structure is designed to ensure that public funds only back technologies that private capital is willing to validate.
Does MII take equity in the companies it funds?
No, MII provides grant funding and does not take equity. The partner universities retain their standard patent rights and licensing agreements with the spinout companies. This grant-based structure avoids the complexity of a public entity holding equity positions, though the investment terms with co-investors typically include standard venture equity instruments.
Which universities are eligible partners?
Five Maryland research universities are eligible: University of Maryland, College Park; University of Maryland, Baltimore; University of Maryland, Baltimore County; Morgan State University; and Johns Hopkins University. Faculty, researchers, and graduate students affiliated with these institutions may apply through their respective technology transfer offices.
How does MII relate to TEDCO?
TEDCO (Maryland Technology Development Corporation) is a separate state-backed entity that runs later-stage venture programs, including the Maryland Venture Fund. MII focuses on pre-seed and seed-stage grants, while TEDCO programs typically invest in companies that have already achieved some commercial traction. The two organizations coordinate on deal referrals but operate with distinct mandates and funding streams.
What is MII's track record on follow-on funding?
According to publicly reported state data, MII has deployed roughly $150M since 2012, with portfolio companies collectively raising over $1.5B in subsequent venture rounds. Several companies have achieved exits, including acquisitions by larger public and private technology firms. The renewal of state funding through FY2025 reflects ongoing bipartisan legislative support for the program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: